Endometriosis is a chronic condition driven by inflammation, nerve sensitization, and abnormal tissue growth, often leading to persistent pelvic pain and reduced quality of life. This review explores how cannabidiol (CBD) and tetrahydrocannabinol (THC) may interact with the body’s endocannabinoid system (ECS), a key regulator of pain, immune response, and hormonal balance. Researchers highlight that […]
Tag: THC
Cannabinoids Reduces Migraine-Like Symptoms in Preclinical Study (pub. Jan 2026)
Migraines are often linked to increased activity of calcitonin gene-related peptide (CGRP), a signaling molecule known to trigger pain sensitivity, light sensitivity, and other migraine symptoms. In this preclinical study, researchers examined whether a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) could reduce migraine-like symptoms caused by central CGRP administration in mice. Scientists used established […]
Phytocannabinoids and Brain Health: Early Evidence in Parkinson’s and Alzheimer’s Models (pub. June 2025)
Neurodegenerative diseases such as Parkinson’s and Alzheimer’s involve the progressive loss of nerve cells, leading to movement problems, memory decline, and cognitive challenges. Because current treatments often only ease symptoms, researchers are exploring whether phytocannabinoids—naturally occurring compounds from the Cannabis sativa plant—might influence the biological processes behind these disorders. This review article summarizes recent preclinical […]